• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC. CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC. CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problems Device Displays Incorrect Message (2591); Gas/Air Leak (2946)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/10/2019
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction tubing leak.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot h328 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot h328 for the reported issue shows no trends.Trends were reviewed for complaint categories, tubing leak and alarm #1: air detected.No trends were detected for each complaint category.This assessment is based on the information available at the time of the investigation.At the time of this report, the analysis of the returned kit is still in progress.A supplemental report will be filed when the analysis is complete.(b)(4).
 
Event Description
The customer called to report that they experienced a tubing leak with their cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment.The customer stated an alarm #1: air detected occurred, and air was visible in the pump tubing organizer (pto) and patient return line after approximately 468 ml of whole blood had been processed.During troubleshooting, the customer noticed that the return pump tubing segment was leaking.The ecp procedure was aborted and no residual blood within the kit was returned to the patient.The patient was reported to be in stable condition.The customer has provided the kit for investigation.
 
Manufacturer Narrative
The cellex photopheresis kit ("kit"), and smart card were returned for investigation.A review of the data recorded on the smart card verified approximately 468 ml of whole blood was processed when an alarm #1: air detected alarm occurred and the treatment was aborted.Physical inspection of the return kit shows the tubing that forms the return pump tubing segment was no longer attached to the "t' inside the pto that joins the tubing to the red cell pump tubing segment, and tubing going to the saline line and return bag outlet line.The root cause for the tubing leak is likely due to a weak solvent bond that was formed during the tube bonding operation.Manufacturing operators that perform the tube bonding function were provided with re-training as a result of this complaint.No further action is required at this time.This investigation is now complete.(b)(4).12-dec-2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS, INC.
bedminster NJ 07921
MDR Report Key9296367
MDR Text Key198759471
Report Number2523595-2019-00130
Device Sequence Number1
Product Code LNR
UDI-Device Identifier20705030200003
UDI-Public(01)20705030200003(10)H328(17)210501
Combination Product (y/n)N
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 12/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/01/2021
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCLXUSA
Device Lot NumberH328
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/17/2019
Initial Date Manufacturer Received 10/10/2019
Initial Date FDA Received11/08/2019
Supplement Dates Manufacturer Received11/12/2019
Supplement Dates FDA Received12/12/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age3 YR
Patient Weight12
-
-